Champalimaud Foundation Installs World’s Highest-Field Preclinical MRI for Neuroscience and Oncology Research
Event summary
- Bruker Corporation commissioned an 18 Tesla BioSpec™ preclinical MRI system at the Champalimaud Foundation in Lisbon, Portugal, on May 26, 2026.
- The system is the world’s highest-field horizontal-bore MRI, offering increased spatial resolution and sensitivity for advanced MRI and MRSI methods.
- Professor Noam Shemesh leads the research, focusing on cancer, metastasis, brain plasticity, and neural activity in preclinical models.
- The 18 Tesla system complements Champalimaud’s existing 16.4 Tesla and 9.4 Tesla MRI systems.
The big picture
Bruker’s installation of the 18 Tesla MRI system at the Champalimaud Foundation underscores the growing demand for ultra-high field MRI in preclinical research. This strategic move aligns with broader industry trends toward advanced imaging technologies that enable deeper insights into biological mechanisms. The system’s ability to support both neuroscience and oncology research positions Bruker as a key player in the post-genomic era, where high-resolution imaging is critical for breakthrough discoveries.
What we're watching
- Research Impact
- How the 18 Tesla system will advance neuroscience and oncology research, particularly in characterizing tissue microstructure and localized metabolism.
- Market Differentiation
- Whether Bruker can sustain its leadership in preclinical imaging through continued innovation in ultra-high field MRI systems.
- Translational Relevance
- The pace at which novel imaging biomarkers discovered using this system will translate into clinical applications.
Related topics